These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 139203)

  • 1. Preservation of in vitro biological functions in regional lymph node lymphocytes in squamous head and neck cancer.
    Saxon A; Portaro J
    Cancer Res; 1977 Apr; 37(4):1159-64. PubMed ID: 139203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
    Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
    Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A correlative analysis of in vitro parameters of cellular immunity in patients with squamous cell carcinoma of the head and neck.
    Deegan MJ; Coulthard SW; Quaiman SJ; Schork MA
    Cancer Res; 1977 Dec; 37(12):4475-81. PubMed ID: 144562
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphoid subpopulation changes in regional lymph nodes in squamous head and neck cancer.
    Saxon A; Portis J
    Cancer Res; 1977 Apr; 37(4):1154-8. PubMed ID: 300279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients.
    Mickel RA; Kessler DJ; Taylor JM; Lichtenstein A
    Cancer Res; 1988 Sep; 48(17):5017-22. PubMed ID: 3409231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
    van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
    Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte-mediated cytotoxicity against tumor cells. III Differentiation of concanavalin A-activated cytotoxic effector cells.
    Waterfield JD; Waterfield EM
    Eur J Immunol; 1976 May; 6(5):317-20. PubMed ID: 136357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of poor CD3 response in head and neck cancer.
    Shibuya TY; Nugyen N; McLaren CE; Li KT; Wei WZ; Kim S; Yoo GH; Rogowski A; Ensley J; Sakr W
    Clin Cancer Res; 2002 Mar; 8(3):745-51. PubMed ID: 11895904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human lymph node lymphocytes fail to effect lysis of antibody-coated target cells.
    O'Toole C; Saxon A; Bohrer R
    Clin Exp Immunol; 1977 Jan; 27(1):165-71. PubMed ID: 300304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory activity in regional lymph nodes.
    Houck JR; Panje WR; McCormick KJ; Merrick RH
    Arch Otolaryngol; 1983 Dec; 109(12):785-8. PubMed ID: 6605742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell proliferation in the mixed lymphocyte culture does not necessarily result in the generation of cytotoxic T effector cells.
    Röllinghoff M; Pfizenmeier K; Trostmann H; Wagner H
    Eur J Immunol; 1975 Aug; 5(8):560-4. PubMed ID: 135689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
    Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
    Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed leukocyte culture reactivity of lymph node cells regional to transitional cell carcinoma of the bladder.
    Herr HW; Bean MA; Whitmore WF
    Natl Cancer Inst Monogr; 1978 Dec; (49):177-81. PubMed ID: 155221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional immunosuppression in esophageal squamous cancer: evidence from functional studies with matched lymph nodes.
    O'Sullivan GC; Corbett AR; Shanahan F; Collins JK
    J Immunol; 1996 Nov; 157(10):4717-20. PubMed ID: 8906853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro studies of axillary lymph node cells in patients with breast cancer.
    Tsakraklides E; Tsakraklides V; Ashikari H; Rosen PP; Siegal FP; Robbins GF; Good RA
    J Natl Cancer Inst; 1975 Mar; 54(3):549-56. PubMed ID: 1079055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women.
    Cunningham-Rundles S; Filippa DA; Braun DW; Antonelli P; Ashikari H
    J Natl Cancer Inst; 1981 Sep; 67(3):585-90. PubMed ID: 6944530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transference of cell mediated immunity in patients with head and neck cancer.
    Vetto RM; Burger DR
    Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):79-82. PubMed ID: 304143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of regional lymph node in vitro antitumor immunoreactivity histology with colorectal carcinoma.
    Pihl E; Nairn RC; Nind AP; Muller HK; Hughes ES; Cuthbertson AM; Rollo AJ
    Cancer Res; 1976 Oct; 36(10):3665-71. PubMed ID: 1085194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression in a murine B cell leukemia (BCL1): role of an adherent cell in the suppression of primary in vitro antibody responses.
    Anderson SA; Isakson PC; Puré E; Muirhead M; Uhr JW; Vitetta ES
    J Immunol; 1981 Apr; 126(4):1603-7. PubMed ID: 6451649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.